Main

Sections

Features

Choose Your Region

Be the first to know

Topics you care about, straight to your inbox

Your email address

Main

Sections

Features

Default

Be the first to know

Topics you care about, straight to your inbox

Your email address

Experimental weight loss pill shows notable results in trials

Researchers found the pill helped patients on its highest dose loss an average of 15% of their body weight after 36 weeks in a mid-stage trial.

News 12 Staff

•

Jun 26, 2023, 1:14 PM

•

Updated 396 days ago

Share:

Researchers are saying that a new experimental weight loss pill could offer results that rival currently approved injectable therapies.
The New England Journal of Medicine published a study on Eli Lilly’s drug, called Orforglipron, on Friday.
According to the study, 272 patients with an average body weight of about 240 pounds tested the medication.
Researchers found the pill helped patients on its highest dose loss an average of 15% of their body weight after 36 weeks in a mid-stage trial.
Unlike currently approved medicines for weight loss like Ozempic and Wegovy, Orforglipron is a daily pill, not a once-weekly injection.
More from News 12
0:42
Stamford doctor provides free treatment to children with birthmarks

Stamford doctor provides free treatment to children with birthmarks

1:30
Officials: Calls to 988 have increased since its creation 2 years ago

Officials: Calls to 988 have increased since its creation 2 years ago

1:41
Officials: COVID-19 has hit high levels in several states, including Connecticut

Officials: COVID-19 has hit high levels in several states, including Connecticut

0:44
Mosquitoes trapped in Old Greenwich test positive for West Nile virus

Mosquitoes trapped in Old Greenwich test positive for West Nile virus

2:03
Poll: More than 40% of women skip or delay medical screenings and appointments

Poll: More than 40% of women skip or delay medical screenings and appointments

1:38
Compassionate care: Connecticut honors The Patient is U Foundation nonprofit

Compassionate care: Connecticut honors The Patient is U Foundation nonprofit